Doctor profile · Federal record

Dr. Michael Watterson, MD, FACR

Rheumatology Physician (CMS: Rheumatology) · Greenville, NC

  • NPI 1477548584
  • Accepts Medicare
  • 31 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1850 W Arlington Blvd
Greenville, NC 278345704
(252) 752-6101
fax (252) 752-6600

Credentials & registration

NPPES · NUCC
NPI registered
September 2005 — 21 yrs on file
Profile last updated
August 26, 2021
Year of graduation
1995 — 31 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
North Carolina #2021-01962

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1477548584. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
30,047
Distinct HCPCS
10
Medicare allowed
$847,673
HCPCS Description Services Patients Avg allowed
J1602 Injection, golimumab, 1 mg, for intravenous use 11,250 16 $13
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 7,225 15 $40
J1745 Injection, infliximab, excludes biosimilar, 10 mg 3,375 18 $33
J0897 Injection, denosumab, 1 mg 2,400 32 $23
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 1,144 88 $1
99214 Established patient office or other outpatient visit, 30-39 minutes 1,007 511 $122
80053 Blood test, comprehensive group of blood chemicals 406 204 $10
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 402 194 $8
36415 Insertion of needle into vein for collection of blood sample 333 211 $8
96413 Administration of chemotherapy into vein, 1 hour or less 326 58 $121

In context: peer comparison

Among 3 peers in Greenville Rheumatology Physician, average services per provider: 742. This provider delivers 40× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$702
Transactions
48
Manufacturers
8
Payer (manufacturer) Industry Txns Amount
Ucb, INC. 3 $208.96
Abbvie INC. 18 $208.34
Amgen INC. 18 $150.16
GlaxoSmithKline, LLC. 4 $61.15
Pfizer INC. 2 $26.36
Janssen Biotech, INC. 1 $16.94
Fresenius Kabi USA, LLC 1 $15.04
AstraZeneca Pharmaceuticals Lp 1 $14.67

By nature of payment

Food and Beverage
$702

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
4,537
Patients
1,245
Total drug cost
$1,203,988
Drug Type Claims Patients Total cost
Prednisone Generic 1,305 380 $11,076
Methotrexate (Methotrexate Sodium) Brand 756 181 $21,182
Hydroxychloroquine Sulfate Generic 617 173 $30,436
Tramadol Hcl Generic 286 94 $3,219
Gabapentin Generic 247 74 $3,791
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 226 72 $5,422
Duloxetine Hcl Generic 212 53 $3,330
Methylprednisolone Generic 149 37 $5,323
Humira(Cf) Pen (Adalimumab) Brand 137 19 $1,106,372
Meloxicam Generic 113 37 $769

Frequently asked questions

Auto-generated from federal data
What is Dr. Michael Watterson's medical specialty?
Dr. Michael Watterson practices Rheumatology Physician in Greenville, NC.
Where does Dr. Michael Watterson practice?
Dr. Michael Watterson practices at 1850 W Arlington Blvd, Greenville, NC 278345704. Office phone: 2527526101.
What is Dr. Michael Watterson's NPI?
Dr. Michael Watterson's National Provider Identifier (NPI) is 1477548584, issued by NPPES.
Does Dr. Michael Watterson accept Medicare assignment?
Yes. Dr. Michael Watterson accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Watterson commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.